N-(4-Methylphenyl)-2-(1,2,3,4-tetrahydroquinolin-1-yl)acetamide

Catalog No.: 
ACTHTH250
CAS No.: 
89474-19-1
Molecular Formula: 
C18H20N2O
Molecular Weight: 
280.37
N-(4-Methylphenyl)-2-(1,2,3,4-tetrahydroquinolin-1-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$108.00InquiryInquiry
1g90%$340.00InquiryInquiry
5g90%$1683.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Methylphenyl)-2-(1,2,3,4-tetrahydroquinolin-1-yl)acetamide
IUPAC Name2-(3,4-dihydroquinolin-1(2H)-yl)-N-(p-tolyl)acetamide
Molecular FormulaC18H20N2O
Molecular Weight280.37
SMILESO=C(NC1=CC=C(C)C=C1)CN2CCCC3=C2C=CC=C3
InChI KeyKSOBHNOKCKXKFY-UHFFFAOYSA-N
SynonymN-(4-methylphenyl)-2-(1,2,3,4-tetrahydroquinolin-1-yl)acetamide;2-[3,4-DIHYDRO-1(2H)-QUINOLINYL]-N-(4-METHYLPHENYL)ACETAMIDE;1(2H)-Quinolineacetamide, 3,4-dihydro-N-(4-methylphenyl)-
CAS No.89474-19-1

Synthetic Route by SureRoute

1. ACTHTH250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHPJF548 route compound structure diagram
    ACHPJF548635-46-1In Stock
  4. Then
  5. ACTHTH250 route product structure diagram
    ACTHTH25089474-19-1
Inquiry

2. ACTHTH250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHEVG894 route compound structure diagram
    ACHEVG89416634-82-5In Stock
  2. Plus
  3. ACHPJF548 route compound structure diagram
    ACHPJF548635-46-1In Stock
  4. Then
  5. ACTHTH250 route product structure diagram
    ACTHTH25089474-19-1
Inquiry

3. ACTHTH250 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTHTH250 route product structure diagram
    ACTHTH25089474-19-1
Inquiry

Comments (0)